Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism

Neoplasia

Volumn 9, Issue 11, 2007, Pages 900-908

  Galiè, Mirco ^a   Farace, Paolo ^a   Nanni, Cristina ^b   Spinelli, Antonello ^b   Nicolato, Elena ^a   Boschi, Federico ^a   Magnani, Paolo ^a   Trespidi, Silvia ^b   Ambrosini, Valentina ^b   Fanti, Stefano ^b   Merigo, Flavia ^a   Osculati, Francesco ^a   Marzola, Pasquina ^a   Sbarbati, Andrea ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Metabolism; MRI; PET; Tumor; Vasculature

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; EPITHELIAL STROMAL CELL INTERACTION; EPITHELIUM TUMOR; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STROMA CELL; TUMOR VOLUME;

EID: 36048988035     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07541     Document Type: Article

References (53)

1. 18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia 7, 369-379.
2. Kurokawa T, Yoshida Y, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, and Kotsuji F (2004). Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. Int J Cancer 109, 926-932.
3. 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. J Nucl Med 44, 192-197.
4. Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, Honda T, Inokuma T, Katsushima S, Ohshio G, et al. (1998). FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 39, 1727-1735.
5. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, and Steinert HC (2003). Staging of non - small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348, 2500-2507.
6. Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, et al. (2006). Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65, 143-151.
7. 18F-FDG PET definition of gross tumor volume for radiotherapy of non - small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 47, 1808-1812.
8. Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, and Grégoire V (2004). Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233, 93-100.
9. van Baardwijk A, Baumert BG, Bosmans G, van Kroonenburgh M, Stroobants S, Gregoire V, Lambin P, and De Ruysscher (2006). The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 32, 245-260.
10. Koukourakis MI, Giatromanolaki A, Harris AL, and Sivridis E (2006). Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66, 632-637.
11. Warburg O (1956). On the origin of cancer cells. Science 123, 309-314.
12. Robey IF, Lien AD, Welsh SJ, Baggett BK, and Gillies RJ (2005). Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 7, 324-330.
13. Pouyssegur J, Dayan F, and Mazure NM (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443.
14. Liu D and Hornsby PJ (2007). Fibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect. Neoplasia 9, 418-426.
15. 31P NMR. Proc Natl Acad Sci USA 90, 2646-2650.
16. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, et al. (2006). Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 82, 699-757.
17. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, and Weinberg RA (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
18. Zechmann CM, Woenne EC, Brix G, Radzwill N, Ilg M, Bachert P, Peschke P, Kirsch S, Kauczor HU, Delorme S, et al. (2007). Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors. Neoplasia 9, 57-67.
19. Bhowmick NA, Neilson EG, and Moses HL (2004). Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337.
20. Walker RA (2001). The complexities of breast cancer desmoplasia. Breast Cancer Res 3, 143-145.
21. Beatty JD, Atwood M, Tickman R, and Reiner M (2006). Metaplastic breast cancer: clinical significance. Am J Surg 191, 657-664.
22. Barnes PJ, Boutilier R, Chiasson D, and Rayson D (2005). Metaplastic breast carcinoma: clinical - pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat 91, 173-178.
23. Hill R, Song Y, Cardiff RD, and Van Dyke T (2005). Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123, 1001-1011.
24. Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, and Disis ML (2006). Immunoediting of cancers may lead to epithelial to mesenchymal transition. J Immunol 177, 1526-1533.
25. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, and Chodosh LA (2005). The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8, 197-209.
26. Knutson KL, Almand B, Dang Y, and Disis ML (2004). Neu antigen - negative variants can be generated after neu-specific antibody therapy in neu transgenic mice. Cancer Res 64, 1146-1151.
27. Galiè M, Sorrentino C, Montani M, Micossi L, Di Carlo E, D'Antuono T, Calderan L, Marzola P, Benati D, Merigo F, et al. (2005). Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. Carcinogenesis 26, 1868-1878.
28. Ferrier MC, Sarin H, Fung SH, Schatlo B, Pluta RM, Gupta SN, Choyke PL, Oldfield EH, Thomasson D, and Butman JA (2007). Validation of dynamic contrast-enhanced magnetic resonance imaging - derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia 9, 546-555.
29. Marzola P, Ramponi S, Nicolato E, Lovati E, Sandri M, Calderan L, Crescimanno C, Merigo F, Sbarbati A, Grotti A, et al. (2005). Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents. Invest Radiol 40, 421-429.
30. Spinelli AE, D'Ambrosio D, Pettinato C, Trespidi S, Nanni C, Ambrosini V, Baldazzi G, Bergamini C, and Marengo M (2006). Performance evaluation of a small animal PET scanner. Spatial resolution characterization using 18-FDG-PET and 11-C. Nucl Instrum Methods 571, 215-218.
31. Pathak AP, Artemov D, Ward BD, Jackson DG, Neeman M, and Bhujwalla ZM (2005). Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res 65, 1425-1432.
32. 18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med 27, 731-743.
33. Marzola P, Degrassi A, Calderan L, Farace P, Nicolato E, Crescimanno C, Sandri M, Giusti A, Pesenti E, Terron A, et al. (2005). Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma. Clin Cancer Res 11, 5827-5832.
34. Marzola P, Farace P, Calderan L, Crescimanno C, Lunati E, Nicolato E, Benati D, Degrassi A, Terron A, Klapwijk J, et al. (2003). In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int J Cancer 104, 462-468.
35. 1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. Clin Cancer Res 4, 949-955.
36. van Laarhoven HW, de Geus-Oei LF, Wiering B, Lok J, Rijpkema M, Kaanders JH, Krabbe PF, Ruers T, Punt CJ, van der Kogel AJ, et al. (2005). Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET. Radiology 237, 181-188.
37. Galie M, D'Onofrio M, Montani M, Amici A, Calderan L, Marzola P, Benati D, Merigo F, Marchini C, and Sbarbati A (2005). Tumor vessel compression hinders perfusion of ultrasonographic contrast agents. Neoplasia 7, 528-536.
38. Raman V, Artemov D, Pathak AP, Winnard PT Jr, McNutt S, Yudina A, Bogdanov A Jr, and Bhujwalla ZM (2006). Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Res 66, 9929-9936.
39. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, and West C (2001). Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 7, 928-934.
40. Zhu Q, Kurtzma SH, Hegde P, Tannenbaum S, Kane M, Huang M, Chen NG, Jagjivan B, and Zarfos K (2005). Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers. Neoplasia 7, 263-270.
41. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, and Harris AL (2005). Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 7, 1-6.
42. Gibson GR, Qian D, Ku JK, and Lai LL (2005). Metaplastic breast cancer: clinical features and outcomes. Am Surg 71, 725-730.
43. Sivridis E, Giatromanolaki A, and Koukourakis MI (2005). Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol 58, 1033-1038.
44. Tsarfaty G, Stein GY, Moshitch-Moshkovitz S, Kaufman DW, Cao B, Resau JH, Vande Woude GF, and Tsarfaty I (2006). HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met. Neoplasia 8, 344-352.
45. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, and Comoglio PM (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361.
46. Anderson GR, Stoler DL, and Scarcello LA (1989). Normal fibroblasts responding to anoxia exhibit features of the malignant phenotype. J Biol Chem 264, 14885-14892.
47. Gardner LB, Li F, Yang X, and Dang CV (2003). Anoxic fibroblasts activate a replication checkpoint that is bypassed by E1a. Mol Cell Biol 23, 9032-9045.
48. De Wever O and Mareel M (2003). Role of tissue stroma in cancer cell invasion. J Pathol 200, 429-447.
49. Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, et al. (2002). Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 20, 379-387.
50. Miles KA, Griffiths MR, and Keith CJ (2006). Blood flow - metabolic relationships are dependent on tumour size in non - small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 33, 22-28.
51. Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, and Ezzat AA (2006). Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 45, 188-195.
52. Thiery JP and Sleeman JP (2006). Complex networks orchestrate epithelial - mesenchymal transitions. Nat Rev Mol Cell Biol 7, 131-142.
53. Frank SJ, Chao KS, Schwartz DL, Weber RS, Apisarnthanarax S, and Macapinlac HA (2005). Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Nat Clin Pract Oncol 2, 526-533.